Financial Results for the Quarter and Year ended 31.03.2026
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fischer Medical Ventures reported standalone revenue of Rs. 1,739.18 lakhs for FY26, a massive 233% increase from Rs. 521.97 lakhs in FY25. However, the company swung to a standalone net loss of Rs. 1,042.29 lakhs compared to a profit of Rs. 66.32 lakhs in the prior year. On consolidated basis, revenue slightly declined by 3.3% to Rs. 9,773.04 lakhs from Rs. 10,109.52 lakhs, with consolidated net loss of Rs. 711.94 lakhs versus profit of Rs. 1,923.48 lakhs in FY25. Finance costs surged significantly to Rs. 465.23 lakhs (standalone) from Rs. 13.17 lakhs in the prior year, indicating increased debt burden. The company declared a dividend of Rs. 0.05 per share and appointed new internal auditors. Statutory auditors issued an unmodified opinion. The company underwent a stock split (Rs. 10 to Re. 1) during the year.
The company shows strong top-line growth on standalone basis but has turned loss-making with significantly increased finance costs and negative operating cash flow of Rs. 290.62 lakhs. This suggests potential liquidity stress and high leverage concerns despite the revenue expansion.